Intestinal Lymphangiectasia: Insights on Management and Literature Review. - Wikidata - awgldk - TriplyDB

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

http://www.wikidata.org/entity/Q37118814

about

Exacerbation of primary intestinal lymphangiectasia during late pregnancy and recovery after delivery: A case report and literature review.Primary Intestinal Lymphangiectasia (Waldmann's Disease) Presenting with Chylous Effusions in a 15-Year-Old.

P2860

Q41622095-F5EE1EFF-0601-4048-8519-BE64C2E20A0D Q42367047-5915F0AD-E57C-423C-B826-9164D18D1A3D

P2860

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

http://www.wikidata.org/entity/Q37118814

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@en

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@nl

type

label

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@en

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@nl

prefLabel

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@en

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@nl

P1433

Q37118814-118BC21D-0FCF-4E8C-8ED6-1D9F2A04BE65

P1476

Q37118814-44DDE1A5-6EE6-4EC4-AAB3-02829363CD73

P2093

Q37118814-23A10A2E-6FB2-4F9B-8AC9-6CF092C94A29

Q37118814-2EC46321-13E1-4AE1-8B8F-F9EA520A33EC

Q37118814-48C698AE-50B2-4A56-8AFB-04CDDF6EA96A

Q37118814-9AB20DAE-8A6B-4AF8-B2BA-D678FF1A71AF

Q37118814-CC8B5F64-88E3-4422-A1D4-BB4B4F3C0B55

Q37118814-E7E041B5-90BF-4C15-B887-2F64E6447777

P2860

Q37118814-09CE22B5-2AB2-4658-9CE3-98E6CC07B8D2

Q37118814-11229E22-A580-49C0-A1A0-C4E75E891288

Q37118814-1D97775A-935A-465C-82D3-B2DB92419EE9

Q37118814-3EF1D8B5-628A-4F49-B665-60A1A47771FC

Q37118814-77D2CAC2-D4EE-47B3-9D37-3E6999FA3193

Q37118814-867418FE-2C92-4F93-9A36-A36BF12FE521

Q37118814-A47F8CDA-F78F-4733-BDA3-7CBE730683F3

Q37118814-BF1801F6-3F35-44FC-AFA7-5A7A4945AB9A

Q37118814-CD81C210-ED6B-40DA-AB14-226D92A7417C

Q37118814-CF59D00B-F706-4D63-9F26-5BF57B38BBE0

P304

Q37118814-B7C9486F-E64D-4143-B4A9-CCDD43E618DC

P31

Q37118814-59BFBBFD-3788-44E4-BAFF-0F7AECB8345D

Q37118814-BE9984C8-5AA9-4B3A-BB6F-9DE761ABB09C

P356

Q37118814-EBAF0BEB-1980-43CC-8C0C-B27D901BEB5E

P478

Q37118814-B46E535A-A8CF-474F-9613-C3D45C47D4F3

P50

Q37118814-5B7E2FDB-0761-490F-803F-A872CA95F313

P577

Q37118814-D2339BCD-942A-4BF8-A257-D8C715187C45

P698

Q37118814-403C2679-6FB7-4725-B65A-58F0BE314DAD

P921

Q37118814-4094DFCC-D9E3-4049-B23A-EB72408B13FF

Q37118814-4480DC43-F63C-4E52-B6E6-FC1A3C5A512C

Q37118814-893BD504-E198-4D7C-91CC-4847296CD575

P932

Q37118814-C262E77F-975A-481C-B99D-2D025DAC47FB

P356

P1433

The American journal of case reports

P1476

Intestinal Lymphangiectasia: Insights on Management and Literature Review.

@en

P2093

Aladdin Addas

http://www.w3.org/2001/XMLSchema#string

Haitham Kurabi

http://www.w3.org/2001/XMLSchema#string

Joud M Talas

http://www.w3.org/2001/XMLSchema#string

Mahmoud Nasser

http://www.w3.org/2001/XMLSchema#string

Saf Zazou

http://www.w3.org/2001/XMLSchema#string

Salem I Noureldine

http://www.w3.org/2001/XMLSchema#string

P2860

Primary intestinal lymphangiectasia (Waldmann's disease)

Protein-Losing Enteropathy: Case Illustrations and Clinical Review

Primary intestinal lymphangiectasia successfully treated with octreotide.

A case with intestinal lymphangiectasia successfully treated with slow-release octreotide.

Pleurectomy for chylothorax associated with intestinal lymphangiectasia.

Late-onset primary intestinal lymphangiectasia successfully managed with octreotide: a case report.

Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.

Type I intestinal lymphangiectasia treated successfully with slow-release octreotide.

[Primary intestinal lymphangiectasia: effectiveness of treatment with slow-release octreotide].

Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model.

P304

512-522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/AJCR.899636

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Mohamad J Alshikho

P577

2016-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27440277

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

intestinal lymphangiectasis

P932

4957630

http://www.w3.org/2001/XMLSchema#string